Assembly Biosciences Inc (ASMB)
Healthcare
Biotechnology
25.10 $
-3.6%
vs. previous close
Closing price · As of: 31. Jul 2026
Assembly Biosciences Inc (ASMB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -22 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -14 | -14 | 74 | -18 | -17 | -15 | -0.4 | -23 | -17 | -15 | 14 | -22 | -40 | |
| 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| 1.2 | 1.1 | 1.0 | 0.7 | 0.8 | 0.8 | 0.8 | 0.7 | 0.8 | 1.7 | 1.5 | 1.1 | 5.1 | |
| 1.9 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 1.3 | -1.2 | 83 | -9.2 | -6.2 | -6.0 | 9.4 | -15 | -7.3 | -7.2 | -8.7 | -14 | -37 | |
| 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| -8.4 | 19 | -90 | 17 | 5.1 | 24 | -6.7 | 6.6 | 17 | -158 | 21 | -5.4 | -125 | |
| 0.1 | 0.0 | 9.2 | 0.0 | 12 | 0.0 | 17 | 1.9 | 0.4 | 172 | 0.5 | 0.1 | 173 | |
| -22 | 5.0 | -6.8 | -1.1 | 0.5 | 9.2 | 9.9 | -15 | 0.6 | -1.5 | 36 | -27 | 7.7 | |
| -14 | -14 | 74 | -18 | -17 | -15 | -0.4 | -23 | -17 | -15 | 14 | -22 | -40 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.